Mendelian randomization to evaluate the effect of plasma vitamin C levels on the risk of Alzheimer’s disease.

Until now, observational studies have explored the impact of vitamin C intake on Alzheimer’s disease (AD) risk, however, reported ambiguous findings. To develop effective therapies or prevention, the causal link between vitamin C levels and AD should be established.